Integrated Core Strategies (US) LLC 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-05 4:15 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Integrated Core Strategies (US) LLC | 1,628,534 1.900% | -1,851,096 (-53.20%) | Filing |
| 2024-01-25 4:09 pm Purchase | 2024-01-18 | 13G | Terns Pharmaceuticals, Inc. TERN | Integrated Core Strategies (US) LLC | 3,479,630 5.600% | 3,479,630 (New Position) | Filing |